Source disclosure: January 29, 2026
CHUGAI PHARMACEUTICAL CO.,LTD. [4519.T]
TOKYO — Chugai Pharmaceutical Co., Ltd. announced on January 29, 2026, that its board of directors has resolved to propose a dividend distribution based on December 31, 2025, to be discussed at the company's 115th Annual General Meeting scheduled for March 26, 2026.
The proposed dividend includes a per-share payout of 147 yen and a total amounting to 241.92 billion yen. This represents an increase from the previous year’s figures where the per-share dividend was 125 yen and the total amounted to 93.795 billion yen. The effective date for this dividend is set for March 27, 2026, and it will be funded by retained earnings.
Chugai Pharmaceutical aims to maintain stable dividends for shareholders, targeting a payout ratio of approximately 45 percent relative to Core Earnings Per Share (EPS). In fiscal year 2025, the company achieved nine consecutive quarters of increased core operating profit, marking a 13.6 percent growth compared to the previous year. Reflecting these strong results, the final dividend for the current period is planned at 147 yen per share, comprising a regular dividend of 72 yen and a special centennial anniversary dividend of 75 yen. As a result, the annual dividend per share is expected to reach 272 yen, including the regular dividend of 122 yen and the special dividend of 150 yen. This brings the Core Dividend Payout Ratio to 99.3 percent, averaging 54.9 percent over five years.
Looking ahead, Chugai forecasts a dividend of 132 yen per share annually for the next period, with an interim dividend of 66 yen per share. Consequently, the projected Core Dividend Payout Ratio for 2026 is estimated at 44.7 percent, averaging 54.7 percent over five years. These measures align with the company's commitment to providing consistent returns to its investors while maintaining strategic flexibility for future investments.
AI-translated content. 🟡 Confidence: Standard See terms • Original filing